She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.

While glucagon-like peptide-1 receptor agonists (GLP-1RA), such as next-generation obesity treatments such as Hugo Bee and ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

Jenna Bush Hager's new hairstyle, the winners of Shop TODAY's 2025 Beauty Awards, and a new study about whether GLP-1 drugs ...

Bariatric surgery is associated with a significantly greater long-term weight loss than treatment with GLP-1 receptor agonists, a new head-to-head real-world study finds.